Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2015

Jun 19, 2015

31982_dirs_2015-06-19_40a19e4e-f3bf-4e89-88dc-a35f2fe7097b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2015-06-17

Reporting Person: BOUDREAUX GAIL (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-06-17 Stock Option (Right to buy) $9.13 A 40000 Acquired 2025-06-17 Common Stock (40000) Direct

Footnotes

F1: This option grant was approved by Novavax's board of directors on June 17, 2015, subject to shareholder approval of the Novavax, Inc. 2015 Stock Incentive Plan.